ATE213953T1 - Ein wachstumshormon und leucin enthaltende pharmazeutische formulierung - Google Patents

Ein wachstumshormon und leucin enthaltende pharmazeutische formulierung

Info

Publication number: ATE213953T1
Authority: AT; Austria
Prior art keywords: growth hormone; leucine; pharmaceutical formulation; formulation containing; containing growth
Prior art date: 1994-10-13

Application number

AT95933347T

Other languages

English (en)

Inventor

Hans Holmegaard Sorensen

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-13

Filing date

1995-10-13

Publication date

2002-03-15

1995-05-31 Priority claimed from US08/455,886 external-priority patent/US5654278A/en

1995-10-13 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2002-03-15 Application granted granted Critical

2002-03-15 Publication of ATE213953T1 publication Critical patent/ATE213953T1/de

Links

102000018997 Growth Hormone Human genes 0.000 title abstract 2
108010051696 Growth Hormone Proteins 0.000 title abstract 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 title abstract 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 title abstract 2
239000000122 growth hormone Substances 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
238000003776 cleavage reaction Methods 0.000 abstract 1
230000006240 deamidation Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000003647 oxidation Effects 0.000 abstract 1
238000007254 oxidation reaction Methods 0.000 abstract 1
230000007017 scission Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

AT95933347T 1994-10-13 1995-10-13 Ein wachstumshormon und leucin enthaltende pharmazeutische formulierung ATE213953T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US32283894A	1994-10-13	1994-10-13
US08/455,886 US5654278A (en)	1994-10-13	1995-05-31	Composition and method comprising growth hormone and leucine
PCT/DK1995/000410 WO1996011704A1 (en)	1994-10-13	1995-10-13	A pharmaceutical formulation comprising a growth hormone and leucine

Publications (1)

Publication Number	Publication Date
ATE213953T1 true ATE213953T1 (de)	2002-03-15

Family

ID=26983636

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95933347T ATE213953T1 (de)	1994-10-13	1995-10-13	Ein wachstumshormon und leucin enthaltende pharmazeutische formulierung

Country Status (8)

Country	Link
EP (1)	EP0785797B1 (de)
JP (1)	JP4064455B2 (de)
AT (1)	ATE213953T1 (de)
AU (1)	AU699369B2 (de)
DE (1)	DE69525757T2 (de)
ES (1)	ES2172594T3 (de)
IL (1)	IL115592A (de)
WO (1)	WO1996011704A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070179096A1 (en)	1996-04-24	2007-08-02	Novo Nordisk A/S	Pharmaceutical Formulation
AUPQ387599A0 (en)	1999-11-05	1999-12-02	Metabolic Pharmaceuticals Limited	Product and method for control of obesity
JP4711520B2 (ja)	2000-03-21	2011-06-29	日本ケミカルリサーチ株式会社	生理活性ペプチド含有粉末
CA2418960A1 (en)	2000-08-07	2002-02-14	Inhale Therapeutic Systems, Inc.	Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
PE20110543A1 (es) *	2008-08-15	2011-08-04	Ironwood Pharmaceuticals Inc	Formulacion solida oral que comprende linaclotida, cation de calcio y leucina
WO2011020054A1 (en) *	2009-08-13	2011-02-17	Ironwood Pharmaceuticals Inc.	Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists
CA2811001A1 (en) *	2010-09-11	2012-03-15	Ironwood Pharmaceuticals, Inc.	Treatment of constipation-predominant irritable bowel syndrome

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5967228A (ja) *	1982-10-07	1984-04-16	Green Cross Corp:The	寒冷不溶性グロブリンの凍結乾燥方法
EP0303746B2 (de) *	1987-08-21	1998-12-02	Mallinckrodt Group Inc.	Stabilisierung von Wachstumshormonen
DE69232847T2 (de) *	1991-12-20	2003-09-11	Novo Nordisk A/S, Bagsvaerd	Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
SE9201073D0 (sv) *	1992-04-03	1992-04-03	Kabi Pharmacia Ab	Protein formulation

1995
- 1995-10-12 IL IL11559295A patent/IL115592A/xx not_active IP Right Cessation
- 1995-10-13 AT AT95933347T patent/ATE213953T1/de not_active IP Right Cessation
- 1995-10-13 WO PCT/DK1995/000410 patent/WO1996011704A1/en not_active Ceased
- 1995-10-13 JP JP51286396A patent/JP4064455B2/ja not_active Expired - Fee Related
- 1995-10-13 ES ES95933347T patent/ES2172594T3/es not_active Expired - Lifetime
- 1995-10-13 DE DE69525757T patent/DE69525757T2/de not_active Expired - Lifetime
- 1995-10-13 AU AU36054/95A patent/AU699369B2/en not_active Ceased
- 1995-10-13 EP EP95933347A patent/EP0785797B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JPH10507183A (ja)	1998-07-14
ES2172594T3 (es)	2002-10-01
IL115592A0 (en)	1996-01-19
DE69525757T2 (de)	2002-10-17
EP0785797B1 (de)	2002-03-06
EP0785797A1 (de)	1997-07-30
AU3605495A (en)	1996-05-06
JP4064455B2 (ja)	2008-03-19
IL115592A (en)	2000-07-26
AU699369B2 (en)	1998-12-03
WO1996011704A1 (en)	1996-04-25
DE69525757D1 (de)	2002-04-11

Similar Documents

Publication	Publication Date	Title
ATE214614T1 (de)	2002-04-15	Ein wachstumshormon und isoleucin enthaltende pharmazeutische formulierung
KR970706840A (ko)	1997-12-01	성장호르몬 및 발린으로 이루어진 약학적 조성물(a pharmaceutical formulation comprising a growth hormone and valine)
DE69228704D1 (de)	1999-04-22	Stabilisierte pharmazeutische formulierung, die wachstumshormon und asparagin enthält
AU610636B2 (en)	1991-05-23	Stabilised human protein preparations
ATE206308T1 (de)	2001-10-15	Arzneizusammensetzungen enthaltend ein bakterizides permeabilität erhöhendes protein und ein tensid
ATE204297T1 (de)	2001-09-15	Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
AU4697396A (en)	1996-07-24	Peptide, peptide analog and amino acid analog protease inibitors
CA2140255A1 (en)	1994-03-03	Polyarylates Containing Derivatives of the Natural Amino Acid L-Tyrosine
HUP9800049A3 (en)	1999-01-28	Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf
ATE213953T1 (de)	2002-03-15	Ein wachstumshormon und leucin enthaltende pharmazeutische formulierung
ATE404214T1 (de)	2008-08-15	Arzneimittel, welches ein peptid kleiner oder mittlerer grösse enthält
IT1272252B (it)	1997-06-16	Formulazioni liquide di interferone beta
DE59306211D1 (de)	1997-05-22	Diphosphonsäuren und deren salze enthaltende arzneimittel
ES2065696T3 (es)	1995-02-16	Composicion farmaceutica.
HUP9802286A2 (hu)	1999-02-01	Stabilizált gyógyszerkészítmény amely valamely növekedési hormont és legalább egy bázikus aminosavmaradékot és legalább egy savas aminosav maradékot tartalmazó peptidet foglal magában
MX9800358A (es)	1998-07-31	Formulacion farmaceutica estabilizada que comprende una hormona del crecimiento pretratada con zinc y opcionalmente lisina o iones calcio.
AU8375891A (en)	1992-03-19	Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
ZA9710254B (en)	1998-05-28	LH-RH peptide analogues, their uses and pharmaceutical composition containing them.
DE59108261D1 (de)	1996-11-14	Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
ATE145824T1 (de)	1996-12-15	Aerosolformulierung enthaltend fusafungin
AU1879097A (en)	1997-09-16	Fragments of cr1 and their use
CO4230067A1 (es)	1995-10-19	Composicion cosmetica para el cuidado de la piel
IT1241459B (it)	1994-01-17	Composizioni farmaceutiche per la somministrazione rettale di calcitonina

Legal Events

Date	Code	Title	Description
2002-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties